blepharokeratoconjunctivitis
Conditions
Interventions
BKC group :Tacrolimus eye drops
VKC group :Tacrolimus eye drops
Healthy control group:none
Sponsors
Affiliated Second Hospital of Zhejiang University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with blepharokeratoconjunctivitis and vernal keratoconjunctivitis; 2.Voluntarily follow study procedures and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1.Systemic diseases such as diabetes, heart and brain diseases and mental illness; 2.A history of eye surgery, obvious eyelid or ocular surface disease, contact lens wearers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Inflammation cell density;Corneal nerve density;Limbal Vogt fence density;Corneal fluorescein staining;Vision;Intraocular pressure;Eye itching score;Eye discomfort score; | — |
Countries
China
Contacts
Public ContactHuang Xiaodan
Affiliated Second Hospital of Zhejiang University
Outcome results
None listed